Cary J. Claiborne - May 29, 2025 Form 4 Insider Report for ADIAL PHARMACEUTICALS, INC. (ADIL)

Role
Chief Executive Officer, Director
Signature
/s/ Cary J. Claiborne
Stock symbol
ADIL
Transactions as of
May 29, 2025
Transactions value $
$0
Form type
4
Date filed
6/2/2025, 04:01 PM
Previous filing
Dec 5, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Claiborne Cary J Chief Executive Officer, Director 4870 SADLER ROAD,, STE 300, GLEN ALLEN, /s/ Cary J. Claiborne 2025-06-02 0001370930

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ADIL Stock Option (Right to Buy) Award $0 +138K $0.00 138K May 29, 2025 Common Stock 138K $0.69 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests pro rata on a monthly basis over 36 months commencing May 29, 2025.